Resultados de la búsqueda 41 – 60 de 132
Hepatitis B Virus Infection
… routine HBV DNA testing is not recommended. However, if a tenofovir-sparing HIV regimen is being considered, some … people with HIV/HBV coinfection (median age 41 years) on tenofovir-containing antiretroviral therapy (ART), the … yearly (AIII). Special Considerations When Initiating Tenofovir-Sparing ARV Regimens In people without a history …
Immune Activation and Inflammation Among People With HIV Receiving Antiretroviral Therapy
… density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate/emtricitabine plus …
Cardiovascular Complications in People With HIV
… of a first MACE with ART regimens, including ABC versus tenofovir-containing regimens, 33 and an increased MACE … (HDL), and triglycerides have been observed with tenofovir alafenamide (TAF), efavirenz (EFV), all boosted … who received TAF when compared with those who received tenofovir disoproxil fumarate (TDF) in multiple randomized …
Weight Gain in People With Treated HIV
… reverse transcriptase inhibitor (NNRTI)–based and tenofovir disoproxil fumarate (TDF)–based regimens. 6-9 … and the nucleotide reverse transcriptase inhibitor (NRTI) tenofovir alafenamide (TAF), 11,13 especially when compared … . Lake JE, Trevillyan J. Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV. …
Herpes Simplex Virus
… . Abdool Karim SS, Abdool Karim Q, Kharsany AB, et al. Tenofovir gel for the prevention of herpes simplex virus …
Overview
… caused by atazanavir, renal tubulopathy caused by tenofovir disoproxil fumarate) usually can be managed by … . Hill A, Hughes SL, Gotham D, Pozniak AL. Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in …
Special Populations: Adolescents and Young Adults With HIV
… DTG over boosted PI-based regimens. BIC coformulated with tenofovir (TAF) and emtricitabine (FTC) also appears to have … risk of side effects, such as bone and renal toxicity with tenofovir-based drugs in the rapidly growing adolescent. …
Preventing HIV Transmission During Infant Feeding
… infant. 92 NRTIs show more variability than PIs and NNRTIs. Tenofovir concentrations from tenofovir disoproxil fumarate (TDF) are very low in breast … Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk …
Central Nervous System Toxicity
… al. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: … tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice. Antivir Ther . … co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir DF versus continuation of non-nucleoside reverse …
Special Populations: Early (Acute and Recent) HIV Infection
… ARV regimens is recommended b (AIII): Bictegravir (BIC)/tenofovir alafenamide (TAF)/emtricitabine (FTC) Dolutegravir (DTG) with (TAF or tenofovir disoproxil fumarate [TDF]) c plus (FTC or … of the INSTI genotype. c TAF and TDF are two forms of tenofovir that are approved in the United States. TAF has …
Dyslipidemia
… in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other … N, Margusino-Framinan L, et al. Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with …
Special Populations: HIV-2 Infection
… controlled trial comparing raltegravir (RAL) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) to … D, Gallien S, et al. First-line raltegravir/emtricitabine/tenofovir combination in human immunodeficiency virus type 2 … regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for the initial treatment of …
Special Populations: HIV and the Older Person
… to the marked fracture risk. ART regimens that contain tenofovir disoproxil fumarate (TDF), 27 boosted protease … (INSTIs). 28-31 Abacavir (ABC), NRTI-sparing regimens, and tenofovir alafenamide (TAF) may be considered as … density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate/emtricitabine plus …
Special Populations: Substance Use Disorders and HIV
… with HBV/HIV coinfection unless HBV-active drugs (i.e., tenofovir, entecavir) are included in the regimen. As …
Special Populations: Transplantation in People With HIV
… and efficacy of the new regimen before transplant (BIII). Tenofovir alafenamide (TAF) is preferred over tenofovir disoproxil fumarate (TDF) in transplant candidates … = raltegravir; RPV = rilpivirine; RTV = ritonavir; TDF = tenofovir disoproxil fumarate; TDM = therapeutic drug …
Special Populations: Women With HIV
… by HIV and some ARV drugs. 15-18 ARV regimens that contain tenofovir disoproxil fumarate (TDF), ritonavir-boosted … (RAL). 19-22 Abacavir (ABC), NRTI-sparing regimens, and tenofovir alafenamide (TAF) may be considered as … Two small studies showed no difference in plasma levels of tenofovir and RAL between pre- and postmenopausal women. …
Lactic Acidosis
… acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection. J Ren Care . … M, Matsumoto M, Sawamura M. Severe lactic acidosis during tenofovir disoproxil fumarate and cobicistat combination for … Whitsett M, Papadopoulos Z, et al. Successful treatment of tenofovir alafenamide-induced lactic acidosis: a case …
Lipodystrophies and Weight Gain
… Infections Cohort Collaboration Study G. Weight gain on tenofovir alafenamide fumarate-based therapy compared to tenofovir disoproxil fumarate- and abacavir-based therapy in … Townsend CL, Milanzi E, et al. Effectiveness and safety of tenofovir alafenamide in children and adolescents living …
Nephrotoxic Effects
… . Campbell L, Barbini B, Cromarty B, et al. Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir. AIDS. 2024;38(9):1442-1445. Available at: … . Gupta SK, Post FA, Arribas JR, et al. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a …
Osteopenia and Osteoporosis
… S, et al. Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed … B, Wang S, Cheung AM, Mishra S, Tan DH. The effect of tenofovir disoproxil fumarate on bone mineral density: a … X, et al. Vitamin D and calcium supplementation reverses tenofovir-caused bone mineral density loss in people taking …